Pathogenetic treatment for neurotrophic keratopathy

Journal Title: Офтальмологический журнал - Year 2018, Vol 0, Issue 2

Abstract

Introduction. Continuous soft contact lens (SCL) wearing can result in development of neurotrophic keratopathy. Treatment of this pathology is long-term and, in general, symptomatic: tear-substitute, epithelizing, vitaminous, antibacterial, anti-inflammatory therapy. Purpose. To improve a correction method for metabolic alterations in corneal tissues in continuous-SCL-wear-associated neurotrophic keratopathy through using transorbital electrophoresis with 1% thiotriazoline. Material and Methods. We developed a method of treatment for neurotrophic keratopathy which includes a 10 day course of daily transorbital electrophoresis with 1% thiotriazoline as a part of complex therapy. We applied for approval of Author's certificate (application No U 201710621 dated 01 November 2017). Results. Clinical cases of treatment of stage 1 neurotrophic keratopathy are reported. Conclusion. The proposed treatment enables in a short term to significantly decrease pathological changes in corneal tissues in stage 1 neurotrophic keratopathy, to increase comfort in the eyes, to prevent severe complications of neurotrophic keratopathy and soft contact lens wearing.

Authors and Affiliations

T. Gaidamaka, G. Drozhzhyna

Keywords

Related Articles

Neuro-ophthalmological symptoms in pituitary apoplexy

Background: Neuro-ophthalmological symptoms in patients with pituitary apoplexy were subjected to analysis. Impaired circulation in pituitary adenoma causes an atypical clinical course of the disease which makes the earl...

Developing a stress reaction inventory for eye care workers

Background: The job-related burnout rate in eye care workers has been consistently rising. That is why it is important to develop psychodiagnostic instruments for detecting stress reactions, and to make them psychometric...

Changes in immunity characteristics in patients with small (T1) choroidal melanoma after a course of 810-nm diode laser TTT delivered using the developed methodology

Background: Immune response is an important factor for efficacy of choroidal melanoma (CM) treatment. Adequate uveal melanoma (UM) organ-saving treatment and treatment efficacy monitoring requires determining the interac...

Serum VEGF levels in infants at risk for developing retinopathy of prematurity

Background: Because excessive growth of abnormal retinal vessels in the developing eye of the premature infant underlies retinopathy of prematurity (ROP), it may be hypothesized that a change in vascular endothelial grow...

Relationships of vascular endothelial growth factor (VEGFA) with stage of diabetic retinopathy and disease duration in patients with type 2 diabetes mellitus

Background: As there is currently an epidemic of type 2 diabetes mellitus (T2DM), increasing attention should be paid to diabetic retinopathy (DR), a major complication of the disease which can lead to disability and bli...

Download PDF file
  • EP ID EP422096
  • DOI 10.31288/oftalmolzh/2018/2/710
  • Views 134
  • Downloads 0

How To Cite

T. Gaidamaka, G. Drozhzhyna (2018). Pathogenetic treatment for neurotrophic keratopathy. Офтальмологический журнал, 0(2), 7-10. https://europub.co.uk./articles/-A-422096